AMBRX Trademark

Trademark Overview

On Friday, February 7, 2003, a trademark application was filed for AMBRX with the United States Patent and Trademark Office. The USPTO has given the AMBRX trademark a serial number of 78212503. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 11, 2015. This trademark is owned by Ambrx, Inc.. The AMBRX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development for others in the field of protein-based pharmaceutical and diagnostic agents, and protein-based assay reagents

General Information

Serial Number78212503
Word MarkAMBRX
Filing DateFriday, February 7, 2003
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 11, 2015
Registration Number2949882
Registration DateTuesday, May 10, 2005
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 30, 2003

Trademark Statements

Goods and ServicesResearch and development for others in the field of protein-based pharmaceutical and diagnostic agents, and protein-based assay reagents

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 11, 2015
Primary Code042
First Use Anywhere DateFriday, February 7, 2003
First Use In Commerce DateMonday, September 15, 2003

Trademark Owner History

Party NameAmbrx, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037
Party NameAmbrx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Marino, CA 91108
Party NameAmbrx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Marino, CA 91108

Trademark Events

Event DateEvent Description
Friday, December 11, 2015CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Thursday, June 9, 2011REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, June 7, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, May 9, 2011TEAS SECTION 8 & 15 RECEIVED
Tuesday, August 21, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 21, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 4, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 23, 2005ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 23, 2005TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 10, 2005REGISTERED-PRINCIPAL REGISTER
Tuesday, March 1, 2005ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 1, 2005TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 1, 2005LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, January 28, 2005ASSIGNED TO LIE
Thursday, January 27, 2005ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, January 26, 2005AMENDMENT FROM APPLICANT ENTERED
Tuesday, January 11, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 11, 2005PAPER RECEIVED
Tuesday, July 13, 2004NON-FINAL ACTION E-MAILED
Wednesday, June 30, 2004STATEMENT OF USE PROCESSING COMPLETE
Tuesday, June 22, 2004USE AMENDMENT FILED
Wednesday, June 23, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 22, 2004TEAS STATEMENT OF USE RECEIVED
Tuesday, December 23, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 30, 2003PUBLISHED FOR OPPOSITION
Wednesday, September 10, 2003NOTICE OF PUBLICATION
Monday, August 11, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 6, 2003EXAMINERS AMENDMENT E-MAILED
Thursday, July 31, 2003ASSIGNED TO EXAMINER

Related Keywords

ambrx protein based agents assay reagents diagnostic pharmaceutical field development research